GALAPAGOS NV (GLPG.AS) Fundamental Analysis & Valuation

AMS:GLPG • BE0003818359

Current stock price

24.3 EUR
-0.12 (-0.49%)
Last:

This GLPG.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. GLPG.AS Profitability Analysis

1.1 Basic Checks

  • In the past year GLPG was profitable.
  • In the past year GLPG has reported a negative cash flow from operations.
  • In multiple years GLPG reported negative net income over the last 5 years.
  • GLPG had a negative operating cash flow in each of the past 5 years.
GLPG.AS Yearly Net Income VS EBIT VS OCF VS FCFGLPG.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

1.2 Ratios

  • GLPG's Return On Assets of 9.42% is amongst the best of the industry. GLPG outperforms 86.11% of its industry peers.
  • GLPG's Return On Equity of 9.92% is amongst the best of the industry. GLPG outperforms 83.33% of its industry peers.
  • The Return On Invested Capital of GLPG (12.06%) is better than 86.11% of its industry peers.
Industry RankSector Rank
ROA 9.42%
ROE 9.92%
ROIC 12.06%
ROA(3y)5.36%
ROA(5y)1.9%
ROE(3y)6.68%
ROE(5y)1.5%
ROIC(3y)N/A
ROIC(5y)N/A
GLPG.AS Yearly ROA, ROE, ROICGLPG.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 -10

1.3 Margins

  • GLPG has a Profit Margin of 28.85%. This is amongst the best in the industry. GLPG outperforms 86.11% of its industry peers.
  • GLPG has a Operating Margin of 47.04%. This is amongst the best in the industry. GLPG outperforms 95.83% of its industry peers.
  • With an excellent Gross Margin value of 97.33%, GLPG belongs to the best of the industry, outperforming 95.83% of the companies in the same industry.
  • In the last couple of years the Gross Margin of GLPG has declined.
Industry RankSector Rank
OM 47.04%
PM (TTM) 28.85%
GM 97.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.64%
GM growth 5YN/A
GLPG.AS Yearly Profit, Operating, Gross MarginsGLPG.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100 150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. GLPG.AS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so GLPG is still creating some value.
  • Compared to 1 year ago, GLPG has about the same amount of shares outstanding.
  • GLPG has more shares outstanding than it did 5 years ago.
  • GLPG has a better debt/assets ratio than last year.
GLPG.AS Yearly Shares OutstandingGLPG.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
GLPG.AS Yearly Total Debt VS Total AssetsGLPG.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • GLPG has an Altman-Z score of 7.61. This indicates that GLPG is financially healthy and has little risk of bankruptcy at the moment.
  • GLPG has a Altman-Z score of 7.61. This is amongst the best in the industry. GLPG outperforms 83.33% of its industry peers.
  • GLPG has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of GLPG (0.00) is better than 90.28% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 7.61
ROIC/WACC1.49
WACC8.12%
GLPG.AS Yearly LT Debt VS Equity VS FCFGLPG.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 20.15 indicates that GLPG has no problem at all paying its short term obligations.
  • GLPG has a better Current ratio (20.15) than 100.00% of its industry peers.
  • A Quick Ratio of 20.00 indicates that GLPG has no problem at all paying its short term obligations.
  • GLPG's Quick ratio of 20.00 is amongst the best of the industry. GLPG outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 20.15
Quick Ratio 20
GLPG.AS Yearly Current Assets VS Current LiabilitesGLPG.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. GLPG.AS Growth Analysis

3.1 Past

  • GLPG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 334.82%, which is quite impressive.
  • The Revenue has grown by 280.53% in the past year. This is a very strong growth!
  • GLPG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.97% yearly.
EPS 1Y (TTM)334.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3023.68%
Revenue 1Y (TTM)280.53%
Revenue growth 3Y58.87%
Revenue growth 5Y15.97%
Sales Q2Q%1093.22%

3.2 Future

  • The Earnings Per Share is expected to decrease by -23.95% on average over the next years. This is quite bad
  • Based on estimates for the next years, GLPG will show a very negative growth in Revenue. The Revenue will decrease by -32.33% on average per year.
EPS Next Y-141.18%
EPS Next 2Y-67.16%
EPS Next 3Y-45.56%
EPS Next 5Y-23.95%
Revenue Next Year1%
Revenue Next 2Y-2.91%
Revenue Next 3Y-9.92%
Revenue Next 5Y-32.33%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
GLPG.AS Yearly Revenue VS EstimatesGLPG.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M 1B
GLPG.AS Yearly EPS VS EstimatesGLPG.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 -4

More info and screens

Find the best growth stocksShow best growing peers

2

4. GLPG.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 4.99, the valuation of GLPG can be described as very cheap.
  • Compared to the rest of the industry, the Price/Earnings ratio of GLPG indicates a rather cheap valuation: GLPG is cheaper than 97.22% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.15. GLPG is valued rather cheaply when compared to this.
  • GLPG is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 4.99
Fwd PE N/A
GLPG.AS Price Earnings VS Forward Price EarningsGLPG.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -7.41
GLPG.AS Per share dataGLPG.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • GLPG's earnings are expected to decrease with -45.56% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-67.16%
EPS Next 3Y-45.56%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GLPG.AS Dividend Analysis

5.1 Amount

  • No dividends for GLPG!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GLPG.AS Fundamentals: All Metrics, Ratios and Statistics

GALAPAGOS NV

AMS:GLPG (4/28/2026, 5:29:59 PM)

24.3

-0.12 (-0.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-24
Earnings (Next)05-06
Inst Owners25.28%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.60B
Revenue(TTM)1.11B
Net Income(TTM)320.88M
Analysts52.22
Price Target30.17 (24.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9817.73%
Min EPS beat(2)-19965.4%
Max EPS beat(2)329.9%
EPS beat(4)1
Avg EPS beat(4)-5598.11%
Min EPS beat(4)-19965.4%
Max EPS beat(4)329.9%
EPS beat(8)4
Avg EPS beat(8)-2634.25%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)487.56%
Min Revenue beat(2)-2.86%
Max Revenue beat(2)977.98%
Revenue beat(4)2
Avg Revenue beat(4)242.3%
Min Revenue beat(4)-10.27%
Max Revenue beat(4)977.98%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.1%
PT rev (3m)0%
EPS NQ rev (1m)-14.12%
EPS NQ rev (3m)-32.89%
EPS NY rev (1m)18.36%
EPS NY rev (3m)-11.68%
Revenue NQ rev (1m)-0.4%
Revenue NQ rev (3m)-0.81%
Revenue NY rev (1m)1.04%
Revenue NY rev (3m)0.54%
Valuation
Industry RankSector Rank
PE 4.99
Fwd PE N/A
P/S 1.44
P/FCF N/A
P/OCF N/A
P/B 0.49
P/tB 0.5
EV/EBITDA -7.41
EPS(TTM)4.87
EY20.04%
EPS(NY)-2.01
Fwd EYN/A
FCF(TTM)-4.12
FCFYN/A
OCF(TTM)-3.91
OCFYN/A
SpS16.88
BVpS49.1
TBVpS49.09
PEG (NY)N/A
PEG (5Y)N/A
Graham Number73.3514 (201.86%)
Profitability
Industry RankSector Rank
ROA 9.42%
ROE 9.92%
ROCE 16.08%
ROIC 12.06%
ROICexc 153.5%
ROICexgc 154.01%
OM 47.04%
PM (TTM) 28.85%
GM 97.33%
FCFM N/A
ROA(3y)5.36%
ROA(5y)1.9%
ROE(3y)6.68%
ROE(5y)1.5%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.64%
GM growth 5YN/A
F-Score6
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0.01
Cap/Depr 24.8%
Cap/Sales 1.25%
Interest Coverage 1127.48
Cash Conversion N/A
Profit Quality N/A
Current Ratio 20.15
Quick Ratio 20
Altman-Z 7.61
F-Score6
WACC8.12%
ROIC/WACC1.49
Cap/Depr(3y)83.14%
Cap/Depr(5y)94.58%
Cap/Sales(3y)13.02%
Cap/Sales(5y)12.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)334.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3023.68%
EPS Next Y-141.18%
EPS Next 2Y-67.16%
EPS Next 3Y-45.56%
EPS Next 5Y-23.95%
Revenue 1Y (TTM)280.53%
Revenue growth 3Y58.87%
Revenue growth 5Y15.97%
Sales Q2Q%1093.22%
Revenue Next Year1%
Revenue Next 2Y-2.91%
Revenue Next 3Y-9.92%
Revenue Next 5Y-32.33%
EBIT growth 1Y377.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year33.82%
EBIT Next 3Y8.25%
EBIT Next 5Y3.21%
FCF growth 1Y32.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.55%
OCF growth 3YN/A
OCF growth 5YN/A

GALAPAGOS NV / GLPG.AS Fundamental Analysis FAQ

What is the fundamental rating for GLPG stock?

ChartMill assigns a fundamental rating of 5 / 10 to GLPG.AS.


Can you provide the valuation status for GALAPAGOS NV?

ChartMill assigns a valuation rating of 2 / 10 to GALAPAGOS NV (GLPG.AS). This can be considered as Overvalued.


How profitable is GALAPAGOS NV (GLPG.AS) stock?

GALAPAGOS NV (GLPG.AS) has a profitability rating of 5 / 10.


What is the financial health of GALAPAGOS NV (GLPG.AS) stock?

The financial health rating of GALAPAGOS NV (GLPG.AS) is 7 / 10.